APA (7th ed.) Citation

Schlom, J., Palena, C., Fousek, K., Hamilton, D. H., Horn, L. A., Qin, H., . . . Angstadt, S. Fulvestrant increases the susceptibility of enzalutamide-resistant prostate cancer cells to NK-mediated lysis. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Schlom, Jeffrey, Claudia Palena, Kristen Fousek, Duane H. Hamilton, Lucas A. Horn, Haiyan Qin, Madeline Dahut, and Shantel Angstadt. Fulvestrant Increases the Susceptibility of Enzalutamide-resistant Prostate Cancer Cells to NK-mediated Lysis. BMJ Publishing Group.

MLA (9th ed.) Citation

Schlom, Jeffrey, et al. Fulvestrant Increases the Susceptibility of Enzalutamide-resistant Prostate Cancer Cells to NK-mediated Lysis. BMJ Publishing Group.